Recent insider trading activity from Borges Luis, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2024 | Metagenomi Therapeutics, Inc. | $MGX | Borges Luis | Chief Scientific Officer | A | Common Stock | 69316 | $0.00 | 69,316.0000 | 3,884,740 | 9999.99% | 1.78% |
| April 1, 2024 | Metagenomi Therapeutics, Inc. | $MGX | Borges Luis | Chief Scientific Officer | A | Stock Option (Right to Buy) | 291450 | $0.00 | 291,450.0000 | 3,884,740 | 9999.99% | 7.50% |